Drug Patent News Monitoring

The Top 5 Most-Listened to Podcasts of 2024

The top 5 podcast episodes of the year showcase pivotal moments and insights shaping the biosimilar market. Topics range from the approval of the first denosumab biosimilars, which are set to expand treatment options in osteoporosis care, to the …

Patent Case Summaries | Week Ending December 20, 2024

Teva Branded Pharmaceutical Products R&D, Inc., et al. v. Amneal Pharmaceuticals of New York, LLC, et al., No. 2024-1936 (Fed. Cir. (D.N.J.) Dec. 20, 2024). Opinion by Prost, joined by Taranto and Hughes. Teva obtained FDA approval for its ProAir® HFA …

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Nutriband’s abuse-deterrent platform technology is now patented in 46 countries and territories covering major global markets. Nutriband is targeting to file for FDA approval for AVERSA™ Fentanyl in the first half of 2025. ORLANDO, Fla., Dec. 27, 2024 ( …

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Two New Canadian Patents Amid Continued Efforts To Safeguard The ...

(MENAFN- Investor Brand Network) Lexaria has continuously taken steps to protect its intellectual property internationally to safeguard the applicability of its patented DehydraTECH(TM) technology across the globe The company recently announced that it had …

Menopause care formula made with indigenous grass by ICMR-NIN scientists gets patent

Hyderabad: A patent has been granted for work in menopause care conducted at the Indian Council of Medical Research-National Institute of Nutrition (ICMR-NIN) by Dr Vandana Singh, a researcher who worked under the mentorship of Dr B Dinesh Kumar, Former …

China's 30-year journey to becoming powerhouse in international patents

© Provided by Xinhua An aerial drone photo shows a train for China-Europe freight service pulling out of Tongjiang North Railway Port in northeast China's Heilongjiang Province, Aug. 9, 2024. (Photo by Wu Yunan/Xinhua)by Xinhua writer Yuan Quan …

CAFC Decision on Orange Book Listings for Drug/Device Combination Patents

On December 20th, 2024, the Court of Appeals for the Federal Circuit issued an important decision in Teva Branded Pharmaceutical Products R&D v. Amneal Pharmaceuticals that impacts Orange Book (OB) listings for patents related to FDA-approved drug/ …

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Patented Dehydratech(TM) Technology's Effectiveness On GLP-1 Drugs For ...

(MENAFN- Investor Brand Network) Lexaria, a global innovator in drug delivery platforms, recently announced plans to launch new human and animal studies examining whether its patented DehydraTECH(TM) technology can make GLP-1 drugs better Lexaria has …

Yearender-Feature: China's 30-year journey to becoming powerhouse in international patents

by Xinhua writer Yuan Quan BEIJING, Dec. 26 (Xinhua) -- Since joining the Patent Cooperation Treaty (PCT) in 1994, China has grown into a global leader in innovation, with the number of patent applications rising from just 98 to 69,610 last year, …

India’s free trade agreement raises questions about patent oppositions 

In this episode of the State of the Economy podcast, businessline’s Jyothi Dutta talks to Biswajit Dhar, Professor, Jawaharlal Nehru University (Retd) and Distinguished Professor Council for Social Development to reflect on two decades of India’s product …

The Top 5 Most-Read Policy Articles of 2024

The top biosimilar policy articles of 2024 cover key advancements and challenges in the biosimilars market. Highlights include the Biosimilars Council's call for addressing pharmacy benefit manager (PBM) rebate schemes, the FDA's draft guidance to …

Greece’s Pharmaceutical Market Reaches Record €4.72 Billion Amid Rising Prices

Greece’s pharmaceutical prices are rising, though there has been a decrease in the number of pharmaceuticals sold.  There was a nearly 2% rise in sales value in the first nine months of 2024, though the total volume of medicines sold has dropped.  …

Haihe Biopharma patents new AR-v7 degradation inducers

Hydrogels: a broader interpretation for medical use patent protection in Europe

Dr. Heather West and Dr. Nicholas Watermeyer, patent attorneys at European intellectual property firm Withers & Rogers, both specialising in the firm's Life Sciences and Chemistry Group, discuss the growing opportunity to patent hydrogels and …

Patent Tech-AI Law NGO serving disabled people who can't afford attorney (Quantum computers meets law sector): VRN News

CAMBRIDGE, Mass., Dec. 24, 2024 (GLOBE NEWSWIRE) -- Earlier this month, AI Legal Mate, an AI Law research organization that started out as a Harvard class project, has filed its Gen AI 'Law and Health' technology utility patent updates, utilizing …

A new medicine for almost everything – is it too good to be true?

Initially, it was only about type 2 diabetes.  Semaglutide is the active substance in the Wegovy and Ozempic injections produced by the Danish pharmaceutical company Novo Nordisk. Semaglutide works on diabetes by mimicking a natural hormone in the body …

Inhibitors of PERK and GCN2 disclosed in Deciphera patent

Federal appeals court says Teva must delist Orange Book inhaler patents

Neutrolis Licenses University of Illinois Chicago Patent to Advance Topical Dry Eye Disease Therapy Targeting NETs

CAMBRIDGE, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Neutrolis Inc., a clinical stage biotech company focused on targeting Neutrophil Extracellular Traps (NETs) for the treatment of autoimmune and inflammatory diseases, today announced that it has entered …

Auxein Received remarkable response at WIROC 2024 for Its Innovative Orthopaedic Solutions

Division of Auxein Institute For Surgeons(DAIS) in association with Bombay Orthopaedic Society hosted a "Hands-On Workshop" on Meniscus Repair during WIROC 2024 MUMBAI, MUMBAI, INDIA, December 28, 2024 /⁨EINPresswire.com⁩/ -- Auxein, a …

Nonmydriatic Fundus Cameras Market is Projected to Grow to US$ 323.71 Million by 2034 | at a 6.0% CAGR

The growth in healthcare framework, especially in surfacing nations, is driving the market demand. NEW YORK CITY, NY, UNITED STATES, December 27, 2024 /⁨EINPresswire.com⁩/ -- Our nonmydriatic fundus cameras market report has been prepared using …

New Trends in Plastic Surgery & Aesthetic Medicine in 2025

The field of aesthetic medicine is rapidly evolving, driven by advancements in technology, and the increasing demand for minimally invasive procedures. NEWPORT BEACH, CA, UNITED STATES, December 27, 2024 /⁨EINPresswire.com⁩/ -- The Gallery of …

Vietnamese Manufacturer Elevates Hospitality Uniform Standards, Offering Style and Savings to US Restaurants and Hotels

Cost-Effective Luxury: Dony Garment Delivers Premium Hospitality Uniforms to US Businesses HO CHI MINH, VIETNAM, December 28, 2024 /⁨EINPresswire.com⁩/ -- As the US hospitality industry rebounds and competition intensifies, restaurants and hotels …

AJ Peak Launches 'The $500K Secret' to Help Healthcare Professionals Maximize Practice and Property Sales

COLORADO SPRINGS, CO, UNITED STATES, December 27, 2024 /⁨EINPresswire.com⁩/ -- Healthcare professionals spend much of their lives building successful practices, only to discover that when it’s time to sell, they’ve unknowingly left hundreds of …

Revolutionizing Field Service Management: Ascendo AI Delivers AI Coworkers Through Integration with SAP Technology

Ascendo AI integrates with SAP Field Service Management, enabling AI-powered workflows for real-time knowledge creation, troubleshooting, and efficiency. SAN FRANCISCO, CA, UNITED STATES, December 27, 2024 /⁨EINPresswire.com⁩/ -- Ascendo AI, the …

Adam Shakir: Presenting Comprehensive ENT Care at Milton Keynes

MILTON KEYNES, UNITED KINGDOM, December 27, 2024 /⁨EINPresswire.com⁩/ -- Adam Shakir, a well-known Ear, Nose and Throat specialist, has dedicated himself to providing excellent care for disorders of the ear, nose, throat, head and neck. Mr. Shakir …

The Genetic and Environmental Factors Behind ADD

GULFPORT, MS, UNITED STATES, December 27, 2024 /⁨EINPresswire.com⁩/ -- Attention Deficit Disorder (ADD) is a complex neurodevelopmental condition that affects individuals across all age groups, presenting challenges in attention, impulsivity, and …

Calmerry Launches New Male-Oriented Therapeutic Service

NEW CASTLE, NY, UNITED STATES, December 27, 2024 /⁨EINPresswire.com⁩/ -- Calmerry, an online therapy platform of global repute, is proud to announce the launch of a long-anticipated and much-needed therapeutic service—mental health counseling …

OpiAID Ushers in a New Year of Innovation and Hope for Addiction Recovery in 2025

Strategic partnerships and groundbreaking technology position OpiAID to transform recovery access nationwide WILMINGTON, NC, UNITED STATES, December 27, 2024 /⁨EINPresswire.com⁩/ -- As the nation reflects on the challenges of the past year and …

Medsynaptic Unveils ImageDoot: Revolutionary Medical Image Exchange and Patient Engagement Portal

Medsynaptic announces the launch of ImageDoot, a cutting-edge platform designed for the secure exchange, access, and portability of medical images and records. PUNE, MAHARASHTRA, INDIA, December 27, 2024 /⁨EINPresswire.com⁩/ -- Medsynaptic, a …

Age-related Macular Degeneration Treatment Market 2034: FDA Approvals, Drugs, Medication, and Companies by DelveInsight

AMD Companies are Unity Biotechnology, PanOptica, Clearside Biomedical, Alexion Pharmaceuticals, AstraZeneca, Regeneron Pharmaceuticals, Novartis, Roche, etc ALBANY, NY, UNITED STATES, December 27, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s ‘Age- …

Epstein Barr Virus Treatment Market 2034: FDA Approvals, Clinical Trials, Drugs, Medication, Companies by DelveInsight

Epstein Barr Virus Companies are Labo'Life, Atara Biotherapeutics, Eutilex, Marengo Therapeutics, Inc., Cothera Bioscience, Inc, and others ALBANY, NY, UNITED STATES, December 27, 2024 /⁨EINPresswire.com⁩/ -- (Albany, USA) DelveInsight's …

FDA Roundup: December 27, 2024

For Immediate Release: December 27, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA announced recommended changes to labeling for transmucosal buprenorphine products …

Healthcare Physician Staffing Market Projected To Witness Substantial Growth, 2024-2031: AMN Healthcare, Mdstaffers

BURLINGAME, CA, UNITED STATES, December 27, 2024 /⁨EINPresswire.com⁩/ -- Healthcare Physician Staffing Market Trends Overview 2024-2031: A new Report by Coherent Market Insights, titled "Healthcare Physician Staffing Market: Industry Trends …

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has …

Genital Warts Treatment Market 2034: FDA Approvals, Clinical Trials, Therapies, Medication, Companies by DelveInsight

Genital Warts Companies are Medicis Pharmaceuticals, Tamir Biotechnology, Verrica Pharmaceutical, Novan, Graceway Pharmaceuticals, Novartis, MediGene, etc ALBANY, NY, UNITED STATES, December 27, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight's …

Dubai Health Dental Hospital Pediatric Dentistry Clinic Earns Certified Autism Center™ Status

The Dubai Health Dental Hospital Pediatric Dentistry Clinic has become the first healthcare facility in Dubai to earn the Certified Autism Center™ designation. DUBAI, DUBAI, UNITED ARAB EMIRATES, December 27, 2024 /⁨EINPresswire.com⁩/ -- Dubai …

Livestock Parasiticides Market Size is Growing at a CAGR of 6.7% and Reach $4.9 Billion by 2031

WILMINGTON, DE, UNITED STATES, December 27, 2024 /⁨EINPresswire.com⁩/ -- Global Livestock Parasiticides Market Size was at $2.6 billion in 2021, and is estimated to reach $4.9 billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031. The …

FDA approves nivolumab and hyaluronidase-nvhy for subcutaneous injection

On December 27, 2024, the Food and Drug Administration approved nivolumab and hyaluronidase-nvhy (Opdivo Qvantig, Bristol Myers Squibb Company) for subcutaneous injection across approved adult, solid tumor nivolumab (Opdivo, Bristol Myers Squibb Company) …